Mitchell Lawrence Jones - 06 Feb 2023 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Role: Chief Medical Officer
Signature: /s/ Mitchell Jones
Issuer symbol: PALI
Transactions as of: 06 Feb 2023
Net transactions value: -$939
Form type: 4
Filing time: 08 Feb 2024, 16:38:32 UTC
Next filing: 13 Sep 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PALI	Common Stock, par value $0.01	Options Exercise	$0	+4,558	+156%	$0.000000	7,482	06 Feb 2024	Direct	F1
transaction	PALI	Common Stock, par value $0.01	Options Exercise	$0	+2,333	+31%	$0.000000	9,815	06 Feb 2024	Direct	F2
transaction	PALI	Common Stock, par value $0.01	Tax liability	$939	-2,153	-22%	$0.4361	7,662	06 Feb 2024	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PALI	Restricted Stock Units	Options Exercise		-4,558	-9.1%		45,586	06 Feb 2024	Common Stock	4,558		Direct	F4, F5
transaction	PALI	Restricted Stock Units	Options Exercise		-2,333	-8.3%		25,667	06 Feb 2024	Common Stock	2,333		Direct	F4, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on September 5, 2023.
F2	Represents the issuance of common stock upon the vesting and settlement of outstanding restricted stock units for the restricted stock units granted on November 21, 2023.
F3	Represents shares sold on behalf of Reporting Person to satisfy tax requirements related to the vesting of the restricted stock units for each of the vested portions of the grant.
F4	Each restricted stock unit represents the right to receive, at settlement, one share of common stock.
F5	This restricted stock unit was granted on September 5, 2023, and 4,558 restricted stock units subject to the award vested on February 6, 2024, and an additional 45,586 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.
F6	This restricted stock unit was granted on November 21, 2023, and 2,333 restricted stock units subject to the award vested on February 6, 2024, and an additional 25,667 restricted stock units will vest in equal quarterly installments over the remaining portion of the three-year period from the grant date, subject to Reporting Person continuing to be a service provider to Issuer at the time of vesting.